BIOATLA, INC. (BCAB) Debt Components
- 2025-12-31: Debt Instrument, Fair Value DisclosureUSD $4.10M; Debt Instrument, Decrease, ForgivenessUSD (m).
- 2021-09-30: Debt Instrument, Fair Value DisclosureUSD (m); Debt Instrument, Decrease, ForgivenessUSD 9 month · $700.00K.
BIOATLA, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt Instrument, Fair Value Disclosure USD | Debt Instrument, Decrease, Forgiveness USD |
|---|---|---|
| 2025-12-31 | $4.10M | (m) |
| 2021-09-30 | (m) | 9 month · $700.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |